Twenty Years of Cost-effectiveness Analysis in Medical Imaging: Are We Improving?

被引:36
|
作者
Otero, Hansel J. [1 ]
Rybicki, Frank J. [1 ]
Greenberg, Dan [2 ]
Neumann, Peter J. [3 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA
[2] Ben Gurion Univ Negev, Guilford Glazer Sch Business & Management, Dept Hlth Syst Management, IL-84105 Beer Sheva, Israel
[3] Tufts Univ, Sch Med, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA
关键词
D O I
10.1148/radiol.2493080237
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To determine the growth rate, methodologic clarity, and quality changes in cost-effectiveness analyses (CEAs) and to assess whether the U. S. Panel on Cost-effectiveness in Health and Medicine recommendations affected CEA studies in which imaging technologies were evaluated. Materials and Methods: Six databases were systematically searched for CEA reports published between 1985 and 2005. All imaging-related studies were selected and grouped according to year, country, and journal of publication, as well as imaging modality and disease being studied. Two readers with formal training in decision analysis and CEA used a seven-point (1, low; 7, high) Likert scale based on reasonableness of assumptions, quality of presentation, and adherence to guidelines to independently evaluate study quality. Quality scores according to year, country, and journal of publication were compared with the unpaired Student t test. Results: The first radiology- related CEA was published in 1985; 111 radiology- related CEAs were published between 1985 and 2005. The average number of studies increased from 1.6 per year between 1985 and 1995 to 9.4 per year between 1996 and 2005. Eighty-six studies were performed to evaluate diagnostic imaging technologies, and 25 were performed to evaluate interventional imaging technologies. Ultrasonography (35.0%), angiography (31.5%), magnetic resonance imaging (22.5%), and computed tomography (19.8%) were evaluated most frequently. Forty-nine studies received government funds; 42 did not disclose the source of funding. The mean quality score was 4.23 +/- 1.12 ( standard deviation), without significant improvement over time. Scores in studies performed in the United States were significantly higher than scores in studies that were not performed in the United States (4.45 +/- 1.02 vs 3.61 +/- 1.17, respectively; P < .01). Scores were also higher in journals with three or more CEA articles published during the study period than in journals with two or fewer CEA articles published during this period (4.54 +/- 1.09 vs 3.91 +/- 1.06, respectively; P < .01). Conclusion: CEAs are an important tool with which to analyze the value of diagnostic imaging. However, improvement in the quality of analyses is needed. (C) RSNA, 2008
引用
收藏
页码:917 / 925
页数:9
相关论文
共 50 条
  • [1] Cost-effectiveness of medical imaging
    Graham, Michael M.
    [J]. LANCET ONCOLOGY, 2009, 10 (08): : 744 - 745
  • [2] Improving value measurement in cost-effectiveness analysis
    Ubel, PA
    Nord, E
    Gold, M
    Menzel, P
    Prades, JLP
    Richardson, J
    [J]. MEDICAL CARE, 2000, 38 (09) : 892 - 901
  • [3] Cost-Effectiveness of Screening Mammography Beyond Age 75 Years A Cost-Effectiveness Analysis
    Schousboe, John T.
    Sprague, Brian L.
    Abraham, Linn
    O'Meara, Ellen S.
    Onega, Tracy
    Advani, Shailesh
    Henderson, Louise M.
    Wernli, Karen J.
    Zhang, Dongyu
    Miglioretti, Diana L.
    Braithwaite, Dejana
    Kerlikowske, Karla
    [J]. ANNALS OF INTERNAL MEDICINE, 2022, 175 (01) : 11 - +
  • [5] Bayesian cost-effectiveness analysis of medical treatments
    Jen, Min-Hua
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 2021, 184 (04) : 1608 - 1609
  • [6] Bayesian cost-effectiveness analysis of medical treatments
    Shanmugam, Ramalingam
    [J]. JOURNAL OF STATISTICAL COMPUTATION AND SIMULATION, 2019, 89 (18) : 3497 - 3497
  • [7] Cost-effectiveness analysis of medical documentation alternatives
    Kopach, R
    Sadat, S
    Gallaway, ID
    Geiger, G
    Ungar, WJ
    Coyte, PC
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2005, 21 (01) : 126 - 131
  • [8] Incorporating future costs in medical cost-effectiveness analysis: Implications for the cost-effectiveness of the treatment of hypertension
    Johannesson, M
    Meltzer, D
    OConor, RM
    [J]. MEDICAL DECISION MAKING, 1997, 17 (04) : 382 - 389
  • [9] MEDICAL-MANAGEMENT OF GALLSTONES - A COST-EFFECTIVENESS ANALYSIS
    WEINSTEIN, MC
    COLEY, CM
    RICHTER, JM
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 1990, 5 (04) : 277 - 284
  • [10] FOUNDATIONS OF COST-EFFECTIVENESS ANALYSIS FOR HEALTH AND MEDICAL PRACTICES
    WEINSTEIN, MC
    STASON, WB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (13): : 716 - 721